UCB S.A
Smyrna, US · Belgium corporation
Founders & leadership
Board
CV
Cedric van RijckevorselBoard director
CJ
Charles-Antoine JanssenBoard director
ED
Evelyn du MonceauVice Chair.
NO
Norman OrsteinIndependent Director.
AD
Arnoud de PretBoard director
JK
Jean-Pierre KinetIndependent Director.
GM
Gerhard MayrChairman.
AD
Albrecht De GraeveIndependent Director.
KD
Kay DaviesIndependent Director.
Reported raises · per SEC filings
Form D private placements$787.6K disclosed across 1 round · 2015
▶$787.6KraisedMay 2015 · 131 investors · PharmaceuticalsRule 506(b)
▶$787.6KraisedMay 2015 · 131 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Cedric van RijckevorselDirector
- Charles-Antoine JanssenDirector
- Norman OrsteinDirector
- Arnoud de PretDirector
- Jean-Pierre KinetDirector
- Gerhard MayrExecutive Officer, Director
- Michel XavierExecutive Officer
- Albrecht De GraeveDirector
- Jean-Christophe TellierExecutive Officer, Director
- Evelyn du MonceauDirector
- Kay DaviesDirector
- Jeffrey WrenExecutive Officer
- Ctesse du Monceau de BergendalExecutive Officer
- Tom McKillopDirector
- Harriet EdelmanDirector
- Offering amount
- $787.6K
- Amount sold
- $787.6K
- First sale
- Apr 2015
- Incorporated
- Corporation, Belgium
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has UCB S.A raised?
- UCB S.A has disclosed $787.6K raised across 1 round.
- Where is UCB S.A headquartered?
- UCB S.A is headquartered in Smyrna, US.